Dissemination Activities
The iABC project will advance the development of inhaled treatments for patients with Cystic Fibrosis and Bronchiectasis. Below is a list of dissemintation activities relating to the iABC project.
|
Nature of Communication |
Title |
Responsible Participant (and presenter when relevant) |
Date/location when relevant. |
Target audience |
|
Oral presentation at the congress of the European Respiratory Society (ERS), Amsterdam
|
Inhaled antibiotic therapies in Bronchiectasis
|
Prof Stuart Elborn (Belfast, UK) |
September 28, 2015
|
Scientific community
|
|
ERS symposium 2015 in Amsterdam
|
|
Dr James Chalmers (Dundee, UK) |
September 2015 |
Scientific community
|
|
Study information posted on Clinical trials.gov
|
NCT02712983 |
Gerhild Angyalosi (Novartis, CH) |
February 5, 2016
|
Scientific & medical community
|
|
Research Priorities in BE
|
Aliberti S, Masefield S, Polverino E, De Soyza A, Loebinger M, Menendez R, Ringshausen FC, Vendrell M, Powell P, Chalmers JD. Research priorities in bronchiectasis - a consensus statement of the EMBARC Clinical Research Collaboration. European Respiratory Journal in press |
http://www.ncbi.nlm.nih.gov/pub med/27288031 A publication focussed on future directions and priorities for bronchiectasis
|
Sep 2016 |
Scientific community
|
|
1st World Bronchiectasis Conference, Hannover, Germany
|
Project presentation |
Dr James Chalmers |
July 2016 |
Medical community, patients, policymakers
|
|
Poster presentation |
Dose finding study to find the efficacy, safety and tolerability of tobramycin inhalation powder in patients with non-cystic fibrosis bronchiectasis and pulmonary P.aeruginosa infection (iBEST-1) |
Gerhild Angyalosi |
7th July 2017/ World BE conference, Milan |
Scientific community, patients organisations |
|
|
|
|
|
|